VIC Team

VIC Team

Recent Posts

VIC Fellows Spotlight: Sobha Pisharody, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovations from global sources. We are pleased to highlight the...

VIC Tech Expands National Footprint Establishing New Office in Minnesota

Physical presence taps into regional innovation across the upper Midwest Minneapolis-Saint Paul, MN – VIC Technology Venture Development (VIC) today announced that it has begun operations in Minnesota. Dr. Michael...

Dr. Wilbur Lam, Chief Medical Officer of Cellia Science, Elected to the National Academy of Medicine

Fayetteville, AR — Cellia Science, Inc. proudly announces that Dr. Wilbur Lam, MD, PhD, Chief Medical Officer and distinguished scientist in the field of diagnostics and biomedical engineering, has been elected to the...

Inside Pitt Innovation Institute with the Associate Director, Office of Industry & Economic Partnerships Paul-Valentin Pitou

Paul-Valentin joined the Office of Industry and Economic Partnerships in 2017, and currently manages industry and venture capital partnerships at the University of Pittsburgh. Prior, Paul-Valentin worked in the...

Solenic Medical Appoints Jose F. Guzman as Vice President of Strategic Marketing

ADDISON, TEXAS – On behalf of the Solenic team, we welcome Jose F. Guzman to the Solenic Medical team as Vice President of Strategic Marketing. Mr. Guzman has over 25 years of experience in product development, global...

Nob Hill Therapeutics Awarded HHS Phase II Grant for Lung Cancer Therapy

Nob Hill Therapeutics, a respiratory-focused healthcare company, will use the grant funds to develop an inhaled therapy to treat lung cancer. Albuquerque, NM - Nob Hill Therapeutics (NHT), a VIC Technology Venture...

Neurexis Therapeutics: New Discoveries Could Revolutionize Treatment of Alzheimer's and Other Neurological Conditions

Results published in the journal Nature confirm critical role of Calcium Calmodulin Kinase II (CaMKII) enzyme Aurora, CO - Neurexis Therapeutics, a biotechnology company committed to reshaping the landscape of...

Cellia Science Awarded Phase I STTR Grant by National Institute of Biomedical Imaging and Bioengineering to Develop Instrument for Bone Marrow Aspiration Adequacy Assessment

This innovative use of Cellia’s core technology has the potential to improve the quality and reliability of bone marrow aspiration procedures.

VIC Tech Announces New Class of Fellows

The VIC Tech investment model is unique; it sources promising life science innovation directly from universities across the nation, allocating funding to form startup companies and advance these technologies to exit via...

SFC Fluidics Inc. Receives $2 Million SBIR Grant to Develop Groundbreaking Dual Hormone System for Diabetes Care

Next Generation Closed Loop System Designed for Broader Type I Diabetes Patient Population Fayetteville, AR - SFC Fluidics Inc., a medical device company focusing on drug delivery for treatment of Type 1 Diabetes, is...


VIC Tech Announces New Class of Fellows
Our Life Science and Healthcare Future
White Paper
Portfolio Diversification in Times of Market Volatility
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
Solenic Medical, Inc. Announces $5.1M Series A Funding Round Led by Johnson & Johnson Innovation – JJDC, Inc.
VIC Fellows Spotlight: Matthew Leming, PhD
From The Corner Office
From the Corner Office: Michael Artinger, PhD – CEO of Solaris Vaccines, Inc.